View/Open - Scholarly Commons Home

Table 9. Hyperactivity by demographic and cancer characteristics
Abnormal/ Borderline Normal
Socio-demographic characteristics n % n % p*
Gender F 14 19.4 58 80.6 0.71
M 20 22.0 71 78.0
Ethnicity Asian 0 0.0 9 100.0 0.23
Euro 26 22.8 88 77.2
Maori 6 24.0 19 76.0
Pacific 1 6.7 14 93.3
Age Mean 15.5 15.5 0.96
Median 15.6 15.7
Range 12.1 to 19.0 12.0 to 19.1
NZDep06 Mean 5.5 5.6 0.82
Cancer characteristics
Median 5.5 5
Range 1 to 10 1 to 10
Diagnosis
CNS (intracranial &
intraspinal)
5 23.8 16 76.2 0.87
Leukaemia &
Lymphoma
18 21.4 66 78.6
All other 11 19.0 47 81.0
Age at diagnosis Mean 6.6 5.4 0.09
Median 5.1 4.8
Range 0.6 to 14.9 0.0 to 14.3
Time since diagnosis Mean 8.8 10.1 0.05
Median 9.9 10.4
Range 2.5 to 13.9 2.5 to 17.3
Surgery N 16 20.0 64 80.0 0.82
Y 18 21.7 65 78.3
Chemotherapy N 4 20.0 16 80.0 0.96
Y 29 20.4 113 79.6
RT N 29 23.6 94 76.4 0.06
Y 4 10.3 35 89.7
HSCT N 32 22.4 111 77.6 0.08
Y 1 5.3 18 94.7
* Pearson’s Chi-Square used for categorical variables and t-test for continuous variables
There were no differences in reported total difficulties by any demographic or
cancer characteristics (Table 10).
51